The confusion starts when people see dosing instructions that say "take 0.5mg" but their syringe only has unit markings
Yes, you can inject GLP-1 receptor agonist medications into your arm , though it is not always the most commonly recommended site
Like Ozempic, Mounjaro is not included in the GLP-1 Bridge program because it carries a diabetes indication rather than a weight-loss indication
GLP-1 A Specialty-Tier Drug The financial burden for insured consumers can remain substantial even when coverage is approved
However, tirzepatide (Mounjaro), Wegovy (semaglutide), and liraglutide (Nevolat) have all been shown to effectively support weight loss
To view or add a comment, sign in Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology This article highlights a critical point for improving cardiovascular prevention strategies: Because clinicians will not treat what they do not measure, universal screening of hsCRP in both primary and secondary prevention patients, in combination with cholesterol, represents a major clinical opportunity and is therefore recommended
